Generics Drug Market

Generic Drugs		email this page print page
Title		Publication Date		Price
Generics Threats and Opportunities Mounting an Effective Defense Strategy		June 2008		£497
Commercial and Pipeline Insight: Opioids Short Acting and Anti-Abuse Technologies Set to Fragment and Grow The Market		March 2008		£7600
Generic League Market Analysis and Forecasts, 2007-2012, 2017 & 2022		February 2008		£1999
Antipsychotics Market Insight & Analysis 2008		February 2008		£1499
Pregabalin: Pipeline Developer Patent Report		Ongoing		£2080
Generic Drug Market in Canada		February 2008		£695
Stockley's Drug Interactions Pocket Companion		January 2008		£22.95
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry		January 2008		£650
Lifescan Medical Device Company Intelligence Report		December 2007		£295
Therakos Medical Device Company Intelligence Report		December 2007		£195
Cardiovascular Generic Drugs Prospects and Opportunities to 2012		December 2007		£995
Independence Technology Medical Device Company Intelligence Report		December 2007		£295
Vistakon Medical Device Company Intelligence Report		December 2007		£195
Generics Series Key Trends And Events In The 7 Major Markets		December 2007		£2000
Emerging Generic Drug Markets in Europe		December 2007		£795
Combating Generics 2008 Counter-Generics Strategy, Tactics and Execution		December 2007		£3880
Generics Global Industry Guide		October 2007		£525
Consolidation in the Generic Pharmaceutical Industry An evolving landscape		October 2007		£1250
Protein Formulation and Delivery, 2nd edition		September 2007		£115
Pharmaceutical Packaging Handbook		September 2007		£130
Generics in France		August 2007		£125
Generics in Germany		August 2007		£125
Generics in Japan		August 2007		£125
Generics in Italy		August 2007		£125
Generics in China		August 2007		£125
Generics in Belgium		August 2007		£125
Generics in Asia-Pacific		August 2007		£125
Generics in Spain		August 2007		£125
Generics in Europe		August 2007		£125
Generics in Canada		August 2007		£125
Generics in the Netherlands		August 2007		£125
Global Generics		August 2007		£125
Generics in the United States		August 2007		£125
Generics in the United Kingdom		August 2007		£125
Generic Drug Product Development: International Regulatory Requirements		August 2007		£115
Opportunities and Challenges for Generic Drugs in the UK 2007		June 2007		£795
Generic Series: An Introduction to the Canadian Generics Market Key trends and leading companies shaping the market		June 2007		£2000
Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water-Soluble Drugs		June 2007		£115
Generic Drug Product Development: Specialty Drug Products		June 2007		£115
Generic Drug Product Development Bioequivalence		June 2007		£115
Drug Metabolism: Chemical and Enzymatic Aspects		June 2007		£105
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs		May 2007		£995
Indian Bulk Drug Industry Insight 2007		May 2007		£400
Smith & Nephew Medical Device Company Intelligence Report		April 2007		£395
Personal Protective Products in Healthcare Disposable Gloves Worldwide		April 2007		£990
Family Planning Centers in the US IBISWorld Industry Report		April 2007		£325
2007 U.S. Drugs and Health and Beauty Aids Product Lines		April 2007		£99
World Pharmaceutical Markets Fact Book 2006; The		March 2007		£495
Generic Competition, 2007–11 The impact of patent expiries on sales of major drugs		February 2007		£1375
Emerging Generic Drug Companies Worldwide 2007		February 2007		£595
All Other Ambulatory Health Care Services in the US IBISWorld Industry Report		February 2007		£325
Andrx Generics Company Intelligence Report		January 2007		£195
New Dynamics and Challenges in The Generics Market 2007		January 2007		£1870
Terbinafine: Pipeline™ Developer Patent Report		Ongoing		£1825
Sumatriptan: Pipeline™ Developer Patent Report		Ongoing		£2120
Sertraline: Pipeline™ Developer Patent Report		Ongoing		£2120
Roxithromycin: Pipeline™ Developer Patent Report		Ongoing		£2120
Tolterodine: Pipeline™ Developer Patent Report		Ongoing		£1825
Ropivacaine: Pipeline™ Developer Patent Report		Ongoing		£2120
Simvastatin: Pipeline™ Developer Patent Report		Ongoing		£1825
Tamsulosin: Pipeline™ Developer Patent Report		Ongoing		£1825
Cyclosporin (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Detomidine (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Deracoxib (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Doxorubicin: Pipeline™ Selector Patent Report		Ongoing		£210
Enrofloxacin (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Ropinirole: Pipeline™ Developer Patent Report		Ongoing		£2120
Fipronil (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Temozolomide: Pipeline™ Developer Patent Report		Ongoing		£1825
Tacrolimus: Pipeline™ Developer Patent Report		Ongoing		£2460
Valaciclovir: Pipeline™ Developer Patent Report		Ongoing		£2460
Trandolapril: Pipeline™ Developer Patent Report		Ongoing		£2120
Venlafaxine: Pipeline™ Developer Patent Report		Ongoing		£2120
Zoledronic Acid: Pipeline™ Developer Patent Report		Ongoing		£2120
Zolmitriptan: Pipeline™ Developer Patent Report		Ongoing		£2120
Topiramate: Pipeline™ Developer Patent Report		Ongoing		£1825
Orlistat: Pipeline™ Developer Patent Report		Ongoing		£1825
Omeprazole: Pipeline™ Developer Patent Report		Ongoing		£2800
Olanzapine: Pipeline™ Developer Patent Report		Ongoing		£2120
Ondansetron: Pipeline™ Developer Patent Report		Ongoing		£1825
Imidacloprid (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Paclitaxel: Pipeline™ Developer Patent Report		Ongoing		£2800
Oxaliplatin: Pipeline™ Developer Patent Report		Ongoing		£2120
Nicorandil: Pipeline™ Developer Patent Report		Ongoing		£1825
Nebivolol: Pipeline™ Developer Patent Report		Ongoing		£2120
Mometasone: Pipeline™ Developer Patent Report		Ongoing		£2120
Mirtazapine: Pipeline™ Developer Patent Report		Ongoing		£1825
Montelukast: Pipeline™ Developer Patent Report		Ongoing		£1825
Naratriptan: Pipeline™ Developer Patent Report		Ongoing		£2120
Nateglinide: Pipeline™ Developer Patent Report		Ongoing		£1825
Pantoprazole: Pipeline™ Developer Patent Report		Ongoing		£2460
Paroxetine: Pipeline™ Developer Patent Report		Ongoing		£2120
Ramipril: Pipeline™ Developer Patent Report		Ongoing		£2120
Raloxifene: Pipeline™ Developer Patent Report		Ongoing		£2460
Repaglinide: Pipeline™ Developer Patent Report		Ongoing		£1825
Riluzole: Pipeline™ Developer Patent Report		Ongoing		£1825
Risperidone: Pipeline™ Developer Patent Report		Ongoing		£1825
Risedronic Acid: Pipeline™ Developer Patent Report		Ongoing		£2120
Rabeprazole: Pipeline™ Developer Patent Report		Ongoing		£2460
Quinapril: Pipeline™ Developer Patent Report		Ongoing		£2120
Pioglitazone: Pipeline™ Developer Patent Report		Ongoing		£2460
Perindopril: Pipeline™ Developer Patent Report		Ongoing		£2120
Pramipexole: Pipeline™ Developer Patent Report		Ongoing		£1825
Pravastatin: Pipeline™ Developer Patent Report		Ongoing		£2120
Quetiapine: Pipeline™ Developer Patent Report		Ongoing		£2120
Rivastigmine: Pipeline™ Developer Patent Report		Ongoing		£1825
Valsartan: Pipeline™ Developer Patent Report		Ongoing		£2460
Buprenorphine: Pipeline™ Selector Patent Report		Ongoing		£210
Bosentan: Pipeline™ Selector Patent Report		Ongoing		£210
Dasatinib: Pipeline™ Selector Patent Report		Ongoing		£210
Eprosartan: Pipeline™ Selector Patent Report		Ongoing		£210
Erlotinib: Pipeline™ Selector Patent Report		Ongoing		£210
Eptifibatide: Pipeline™ Selector Patent Report		Ongoing		£210
Bimatoprost: Pipeline™ Selector Patent Report		Ongoing		£210
Aliskiren: Pipeline™ Selector Patent Report		Ongoing		£210
Trastuzumab: Pipeline™ Developer Patent Report		Ongoing		£2745
Pyriproxyfen (Vet): Pipeline™ Developer Patent Report		Ongoing		£1790
Trastuzumab: Pipeline™ Selector Patent Report		Ongoing		£210
Vardenafil: Pipeline™ Developer Patent Report		Ongoing		£2460
Vardenafil: Pipeline™ Selector Patent Report		Ongoing		£210
Ertapenem: Pipeline™ Selector Patent Report		Ongoing		£210
Gefitinib: Pipeline™ Selector Patent Report		Ongoing		£210
Tigecycline: Pipeline™ Selector Patent Report		Ongoing		£210
Tazobactam: Pipeline™ Selector Patent Report		Ongoing		£210
Tiotropium Bromide: Pipeline™ Selector Patent Report		Ongoing		£210
Travoprost: Pipeline™ Selector Patent Report		Ongoing		£210
Varenicline: Pipeline™ Selector Patent Report		Ongoing		£210
Tadalafil: Pipeline™ Selector Patent Report		Ongoing		£210
Sunitinib: Pipeline™ Selector Patent Report		Ongoing		£210
Lapatinib: Pipeline™ Selector Patent Report		Ongoing		£210
Glatiramer: Pipeline™ Selector Patent Report		Ongoing		£210
Olmesartan: Pipeline™ Selector Patent Report		Ongoing		£210
Ritonavir: Pipeline™ Selector Patent Report		Ongoing		£210
Sevelamer: Pipeline™ Selector Patent Report		Ongoing		£210
Moxifloxacin: Pipeline™ Selector Patent Report		Ongoing		£210
Moxifloxacin: Pipeline™ Developer Patent Report		Ongoing		£2460
Eplerenone: Pipeline™ Selector Patent Report		Ongoing		£210
Docetaxel: Pipeline™ Selector Patent Report		Ongoing		£210
Memantine: Pipeline™ Selector Patent Report		Ongoing		£210
Pregabalin: Pipeline™ Selector Patent Report		Ongoing		£210
Sirolimus: Pipeline™ Selector Patent Report		Ongoing		£210
Rosiglitazone: Pipeline™ Selector Patent Report		Ongoing		£210
Candesartan: Pipeline™ Selector Patent Report		Ongoing		£210
Zolmitriptan (vet): Pipeline™ Developer Patent Report		Ongoing		£2120
Almotriptan: Pipeline™ Developer Patent Report		Ongoing		£2120
Meloxicam (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Aripiprazole: Pipeline™ Developer Patent Report		Ongoing		£2120
Eletriptan: Pipeline™ Developer Patent Report		Ongoing		£2120
Tiletamine (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Telmisartan: Pipeline™ Selector Patent Report		Ongoing		£210
Topotecan: Pipeline™ Selector Patent Report		Ongoing		£210
Fipronil (Vet): Pipeline™ Developer Patent Report		Ongoing		£2080
Doxorubicin: Pipeline™ Developer Patent Report		Ongoing		£2745
Gatifloxacin: Pipeline™ Selector Patent Report		Ongoing		£210
Imidacloprid (Vet): Pipeline™ Developer Patent Report		Ongoing		£2080
Moxidectin (Vet): Pipeline™ Developer Patent Report		Ongoing		£2460
Midazolam: Pipeline™ Developer Patent Report		Ongoing		£1825
Rosiglitazone: Pipeline™ Developer Patent Report		Ongoing		£2460
Docetaxel: Pipeline™ Developer Patent Report		Ongoing		£2745
Candesartan: Pipeline™ Developer Patent Report		Ongoing		£2460
Eplerenone: Pipeline™ Developer Patent Report		Ongoing		£1790
Meloxicam (vet): Pipeline™ Developer Patent Report		Ongoing		£1790
Memantine: Pipeline™ Developer Patent Report		Ongoing		£1790
Medetomidine (vet): Pipeline™ Selector Patent Report		Ongoing		£210
Octreotide: Pipeline™ Developer Patent Report		Ongoing		£2120
Dorzolamide: Pipeline™ Selector Patent Report		Ongoing		£210
Meropenem: Pipeline™ Developer Patent Report		Ongoing		£2460
Entacapone: Pipeline™ Selector Patent Report		Ongoing		£210
Quinapril: Pipeline™ Selector Patent Report		Ongoing		£210
Raloxifene: Pipeline™ Selector Patent Report		Ongoing		£210
Reboxetine: Pipeline™ Selector Patent Report		Ongoing		£210
Ramipril: Pipeline™ Selector Patent Report		Ongoing		£210
Quetiapine: Pipeline™ Selector Patent Report		Ongoing		£210
Pravastatin: Pipeline™ Selector Patent Report		Ongoing		£210
Paroxetine: Pipeline™ Selector Patent Report		Ongoing		£210
Pantoprazole: Pipeline™ Selector Patent Report		Ongoing		£210
Pergolide: Pipeline™ Selector Patent Report		Ongoing		£210
Perindopril: Pipeline™ Selector Patent Report		Ongoing		£210
Pramipexole: Pipeline™ Selector Patent Report		Ongoing		£210
Pioglitazone: Pipeline™ Selector Patent Report		Ongoing		£210
Repaglinide: Pipeline™ Selector Patent Report		Ongoing		£210
Risedronic Acid: Pipeline™ Selector Patent Report		Ongoing		£210
Tolterodine: Pipeline™ Selector Patent Report		Ongoing		£210
Terbinafine: Pipeline™ Selector Patent Report		Ongoing		£210
Tamsulosin: Pipeline™ Selector Patent Report		Ongoing		£210
Donepezil: Pipeline™ Selector Patent Report		Ongoing		£210
Desloratadine: Pipeline™ Selector Patent Report		Ongoing		£210
Clobetasol Propionate: Pipeline™ Selector Patent Report		Ongoing		£210
Clopidogrel: Pipeline™ Selector Patent Report		Ongoing		£210
Tacrolimus: Pipeline™ Selector Patent Report		Ongoing		£210
Sumatriptan: Pipeline™ Selector Patent Report		Ongoing		£210
Rivastigmine: Pipeline™ Selector Patent Report		Ongoing		£210
Risperidone: Pipeline™ Selector Patent Report		Ongoing		£210
Ropinirole: Pipeline™ Selector Patent Report		Ongoing		£210
Roxithromycin: Pipeline™ Selector Patent Report		Ongoing		£210
Simvastatin: Pipeline™ Selector Patent Report		Ongoing		£210
Sertraline: Pipeline™ Selector Patent Report		Ongoing		£210
Paclitaxel: Pipeline™ Selector Patent Report		Ongoing		£210
Orlistat: Pipeline™ Selector Patent Report		Ongoing		£210
Glimepiride: Pipeline™ Selector Patent Report		Ongoing		£210
Gemcitabine: Pipeline™ Selector Patent Report		Ongoing		£210
Gabapentin: Pipeline™ Selector Patent Report		Ongoing		£210
Irinotecan: Pipeline™ Selector Patent Report		Ongoing		£210
Itraconazole: Pipeline™ Selector Patent Report		Ongoing		£210
Lansoprazole: Pipeline™ Selector Patent Report		Ongoing		£210
Lamotrigine: Pipeline™ Selector Patent Report		Ongoing		£210
Fosinopril: Pipeline™ Selector Patent Report		Ongoing		£210
Fluvoxamine: Pipeline™ Selector Patent Report		Ongoing		£210
Famciclovir: Pipeline™ Selector Patent Report		Ongoing		£210
Ezetimibe: Pipeline™ Selector Patent Report		Ongoing		£210
Fexofenadine: Pipeline™ Selector Patent Report		Ongoing		£210
Finasteride: Pipeline™ Selector Patent Report		Ongoing		£210
Fluvastatin: Pipeline™ Selector Patent Report		Ongoing		£210
Florfenicol (Vet): Pipeline™ Selector Patent Report		Ongoing		£210
Latanoprost: Pipeline™ Selector Patent Report		Ongoing		£210
Leflunomide: Pipeline™ Selector Patent Report		Ongoing		£210
Erythropoietin: Pipeline™ Selector Patent Report		Ongoing		£210
Mirtazapine: Pipeline™ Selector Patent Report		Ongoing		£210
Midazolam: Pipeline™ Selector Patent Report		Ongoing		£210
Mometasone: Pipeline™ Selector Patent Report		Ongoing		£210
Montelukast: Pipeline™ Selector Patent Report		Ongoing		£210
Ondansetron: Pipeline™ Selector Patent Report		Ongoing		£210
Olanzapine: Pipeline™ Selector Patent Report		Ongoing		£210
Metronidazole: Pipeline™ Selector Patent Report		Ongoing		£210
Meloxicam: Pipeline™ Selector Patent Report		Ongoing		£210
Letrozole: Pipeline™ Selector Patent Report		Ongoing		£210
Lercanidipine: Pipeline™ Selector Patent Report		Ongoing		£210
Levetiracetam: Pipeline™ Selector Patent Report		Ongoing		£210
Levofloxacin: Pipeline™ Selector Patent Report		Ongoing		£210
Losartan: Pipeline™ Selector Patent Report		Ongoing		£210
Loratadine: Pipeline™ Selector Patent Report		Ongoing		£210
Citalopram: Pipeline™ Selector Patent Report		Ongoing		£210
Clarithromycin: Pipeline™ Selector Patent Report		Ongoing		£210
Famciclovir: Pipeline™ Developer Patent Report		Ongoing		£2120
Exemestane: Pipeline™ Developer Patent Report		Ongoing		£2120
Erythropoietin: Pipeline™ Developer Patent Report		Ongoing		£2460
Fexofenadine: Pipeline™ Developer Patent Report		Ongoing		£2120
Finasteride: Pipeline™ Developer Patent Report		Ongoing		£2120
Fosinopril: Pipeline™ Developer Patent Report		Ongoing		£2120
Fluvastatin: Pipeline™ Developer Patent Report		Ongoing		£2460
Entacapone: Pipeline™ Developer Patent Report		Ongoing		£1825
Dorzolamide: Pipeline™ Developer Patent Report		Ongoing		£2120
Cladribine: Pipeline™ Developer Patent Report		Ongoing		£1825
Citalopram: Pipeline™ Developer Patent Report		Ongoing		£2120
Clarithromycin: Pipeline™ Developer Patent Report		Ongoing		£2120
Clopidogrel: Pipeline™ Developer Patent Report		Ongoing		£2120
Donepezil: Pipeline™ Developer Patent Report		Ongoing		£2120
Desloratadine: Pipeline™ Developer Patent Report		Ongoing		£1825
Gadopentetate: Pipeline™ Developer Patent Report		Ongoing		£1825
Gemcitabine: Pipeline™ Developer Patent Report		Ongoing		£2120
Letrozole: Pipeline™ Developer Patent Report		Ongoing		£1825
Lercanidipine: Pipeline™ Developer Patent Report		Ongoing		£2460
Leflunomide: Pipeline™ Developer Patent Report		Ongoing		£2120
Levetiracetam: Pipeline™ Developer Patent Report		Ongoing